Phase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancer.

Mahjoubi, M

Phase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancer. [electronic resource] - Cancer investigation 1990 - 477-81 p. digital

Publication Type: Clinical Trial; Journal Article

0735-7907

10.3109/07357909009012071 doi


Aged
Drug Administration Schedule
Humans
Ifosfamide--administration & dosage
Male
Mesna--administration & dosage
Middle Aged
Prostatic Neoplasms--drug therapy
Survival Analysis